It looks tempting but the 6.6% decline in Australian stimulated cycles ....gives a H1FY18 outlook of 20% decline in NPAT....I know there are other cost contributing to the NPAT revision but from first glance it seems to indicate a fair degree of fixed cost or discounting...
As for margin....I don't think their EBITA margin drop (from competition) will always out pace their growth in revenue....as an extreme example if their EBITA margin drops from 30% to 22% (~35% reduction) then revenue has to go up by 50% to maintain EBITA.....
It looks tempting but the 6.6% decline in Australian stimulated...
Add MVF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.005(0.45%) |
Mkt cap ! $465.6M | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.15 | $1.11 | $136.1K | 122.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 23747 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 5156 | 4 |
View Market Depth
| Last trade - 10.19am 19/11/2024 (20 minute delay) ? |
| MVF (ASX) Chart |
